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L. pneumophila was discovered and
named after an outbreak at an American
Legion convention, in 1976.
Currently, at least 150 legionellosis
outbreaks caused by L. pneumophila
have been reported in peer-reviewed
articles.
The outbreak of legionellosis in Murcia
(Spain), in 2001, with a total of 800
suspected cases.
L. pneumophila is commonly found in
natural water systems, soils, and
engineered structures using water.
Cooling towers, air conditioning
systems, water systems, humidifiers,
and whirlpool spas are critical for
L. pneumophila aerosolization.
Disinfection of probable environmental
sources and preventing aerosol
formation are critical for disease
prevention.
The organism is nutritionally fastidious,
requiring L-cysteine and ferric salts.Buffered charcoal–yeast extract agar
supplemented with α-ketoglutarate
medium is used for primary isolation and
cultivation.
L. pneumophila has more than 15
identified serogroups, of which
L. pneumophila serogroup 1 is the main
causative agent of legionellosis.
Virulence factors include flagella,Legionella pneumophila is an intracellular pathogen, ubiquitous in the environment and considered opportunistic. It is the
leading cause of legionellosis, which can be present in its nonpneumonic form (Pontiac fever) and acute pneumonic form
(Legionnaires` disease – LD). In the soil and aquatic systems, L. pneumophila can invade and survive intracellularly in
various protozoans. The ability to proliferate within biofilms provides additional protection from environmental stresses,
such as disinfection. Human infection by L. pneumophila occurs after the inhalation or aspiration of aerosols containing
the pathogen. Upon infection, alveolar macrophages can be invaded and used by L. pneumophila for replication,
resembling the infection of protozoan hosts in the environment. The ability of L. pneumophila to overcome the killing
mechanismsof phagocytes depends on theDot/Icm type IV secretion system – a specializedprotein translocation system
vital for the intracellular survival of the pathogen and for establishing a replicative niche known as the Legionella-containing
vacuole. Following host cell lysis, the released bacteria infect other host cells, beginning a new cycle of infection.fimbriae, types II and IV secretion
systems, and iron-acquisition
mechanisms.
The L. pneumophila genome consists of
a circular chromosome of ~3.3 Mb.
DISEASE FACTS:
Pneumonia is the predominant clinical
manifestation of L. pneumophila
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L. pneumonia accounts for circa 2–15%
of all community-acquired pneumonias
that require hospitalization in Europe and
North America.
Risk groups include individuals over the
age of 50, smokers, and those with




Diagnosis can be confirmed by culture,
Trends in Microbiology | Microbe of the Month
Acknowledgments
This work was financially supported by Base Funding – UIDB/00511/2020 of LEPABE and funded by national funds through the
FCT/MCTES (PIDDAC); Project Biocide_for_Biofilm – PTDC/BII-BTI/30219/2017 – POCI-01-0145-FEDER-030219, pBio4.0 –
POCI-01-0247-FEDER-033298, funded by FEDER funds through COMPETE2020 – Programa Operacional Competitividade e
Internacionalização (POCI) and by national funds (PIDDAC) through FCT/MCTES; Portuguese Foundation for Science and
Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit and BioTecNorte operation (NORTE-
01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020 – Programa
Operacional Regional do Norte.
Declaration of Interests
There are no interests to declare.
Literature
urinary antigen testing, serological














aerobic1. Burillo, A. et al. (2017) Microbiology and epidemiology of Legionnaire's disease. Infect. Dis. Clin. N. Am. 31, 7–27
2. Cianciotto, N. (2001) Pathogenicity of Legionella pneumophila. Int. J. Med. Microbiol. 291, 331–343
3. Chien, M. (2004) The genomic sequence of the accidental pathogen Legionella pneumophila. Science 305, 1966–1968
4. Cunha, B. et al. (2016) Legionnaires' disease. Lancet 387, 376–385
5. Fields, B. (1996) The molecular ecology of legionellae. Trends Microbiol. 4, 286–290
6. Fliermans, C. et al. (1981) Ecological distribution of Legionella pneumophila. Appl. Environ. Microbiol. 41, 9–16
7. Gonçalves, I. et al. (2021) LegionellaDB – A database on Legionella outbreaks. Trends Microbiol. Published online
February 18, 2021. https://doi.org/10.1016/j.tim.2021.01.015
8. Phin, N. et al. (2014) Epidemiology and clinical management of Legionnaires' disease. Lancet Infect. Dis. 14,
1011–1021
9. Swanson, M. and Hammer, B. (2000) Legionella pneumophila pathogenesis: A fateful journey from amoebae to macrophages.
Annu. Rev. Microbiol. 54, 567–613
10. Taylor, M. et al. (2009) Legionella, protozoa, and biofilms: interactions within complex microbial systems. Microbial Ecol.
58, 538–547Trends in Microbiology, September 2021, Vol. 29, No. 9 © 2021 Elsevier Ltd. All rights reserved. https://doi.org/10.1016/j.tim.2021.04.005 861
